“We will likely open up an application option for our production licensees, which means more access for patients.”
Author: Alander Rocha, Georgia Recorder
Georgia’s Medical Cannabis Access Commission approved a new dispensary license Wednesday, bringing the statewide total to 19, after a high patient enrollment threshold that triggered expansion under state law.
The board’s executive director, Andrew Turnage, said the program passed the 25,000 active patient mark some time ago, which allowed the board to approve the additional license. The board voted unanimously to grant a distribution license to FFD Georgia Holdings for a location in Atlanta. The company was the only applicant.
“I always like to share the update when it comes to the number of registered patients because we will likely open up an application option for our production licensees, which means more patient access,” Turnage told the board.
The program is also on track to accept additional licenses, with the number of active patients now at 33,314, moving toward the 35,000 threshold. The law authorizes the commission to issue additional distribution licenses after the 25,000 mark is reached by 10,000 patients.
But despite some progress, the public comment period was dominated by urgent and frustrated expressions from speakers who said the program’s scope is restrictive and limits access and effectiveness. The main complaints centered on product restrictions and stringent qualification requirements, with patients, advocates and other citizens calling for changes that would require legislative action.
The Georgia program, created a decade ago, limits participation to patients with certain conditions, including cancer or seizure disorders. But for some conditions, state law requires that the diagnosis be severe or end-stage.
Lawmakers have considered expanding the program in recent years, and a House study group is examining Georgia’s medical marijuana policies.
Dr. Elmore Alexander, medical director of US 420 Doc, an online service that offers cannabis card reviews, said Georgia’s low-THC oil program lacks the necessary delivery methods to adequately treat patients with complex conditions. The program is “not a mercy program,” he said, and currently banned methods, such as smoke inhalation, could help patients with sudden onset of symptoms like post-traumatic stress disorder.
“I don’t have enough products to take care of (my patients). I don’t have enough,” Alexander said, adding that the state needs to expand the program to include more products that address different conditions.
Several speakers, including former Rep. Micah Gravley, a key figure in the passage of Georgia’s cannabis law, called for the removal of the “serious and terminal” caveats that currently apply to many conditions. They argued that these vague conditions create confusion for doctors because they are not medically based and prevent patients from accessing treatment before their conditions become terminal.
Gravley, who said the state supports expanding the program, said the program’s limited scope was due to a lack of industry knowledge among lawmakers at the time the law was passed.
“I think you had a lot of legislators who were very cautious, who were very nervous to do this, and they really saw the tone and the tenor of the parents their children were putting down, the caregivers were testifying about family members, and so they went out on a limb. Unfortunately, at that time, the limb was too short,” Gravley said.
This story was first published by the Georgia Recorder.